Abstrakt
'Compassionate use' programmes allow medicinal products that are not authorised, but are in the development process, to be made available to patients with a severe disease who have no other satisfactory treatment available to them. We sought to understand how such programmes are regulated in ten European Union countries.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Trials |
Vol/bind | 11 |
Sider (fra-til) | 104 |
ISSN | 1745-6215 |
DOI | |
Status | Udgivet - 1 jan. 2010 |